ABSTRACT
Objective To describe the experience of a tertiary-care center in the management of patients with unexplained dyspnea referred for cardiopulmonary exercise testing (CPX).
Methods All consecutive adults with unexplained dyspnea who underwent CPX at a single tertiary referral center over a ten-year period were included from a prospective registry. We collected data on final diagnosis, routine labs and diagnostic testing including stress/resting echocardiography performed within 6 months of CPX.
Results From 2008 to 2019, 156 patients with unexplained dyspnea were referred for CPX with no prior history of cardiovascular disease, lung disease or neuromuscular disease. A 4-fold increase in referrals was noted during this time period. Analysis of diagnostic work-up revealed marked heterogeneity, particularly according to the specialty of the referring physician. Among the 134 patients who achieved an adequate level of exertion during CPX, 24 (17.9%) and 30 (22.4%) patients had an abnormal age-predicted peak VO2 of < 80% according to Wasserman’s and FRIEND equations respectively. Further analysis revealed 22.5% of patients had a VE/VCO2 slope > 34, suggesting ventilatory inefficiency. Subgroup analysis of 108 patients with complete left ventricular (LV) diastology revealed 13% of patients with a final diagnosis of unexplained dyspnea after CPX were found to have underlying diastolic dysfunction.
Conclusions Our study illustrates an increase in CPX referrals for unexplained dyspnea and associated heterogeneity in diagnostic testing in this population. There is a need for an integrated dyspnea clinic to standardize workflow and facilitate early diagnosis for these patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of Stanford gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Financial support and conflict of interests disclosure: The authors have no conflicts of interest to declare.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.